AVENUE SOLUTIONS

Lobbying for JAZZ PHARMACEUTICALS, INC. · Specialty pharmaceuticals

Filing 4th Quarter - Report

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $50,000.00 income · posted Jan 20, 2026

Lobbying activity 2

Health Issues

Drug safety, prescription drug abuse, value of prescription drugs; Issues related to drug pricing; Expiring healthcare extenders; Issues related to BIOSECURE

Medicare/Medicaid

Issues related to Most Favored Nation (MFN) drug pricing proposal; Issues related to implementation of the Inflation Reduction Act of 2022

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.